Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control

NCT01055353 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01055353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01055353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2010
Enrollment
1,857 (actual)
Sites
905

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive, no known cardiovascular, no known renal disease, target organs damage